Published in Heart Disease Weekly, April 24th, 2005
The findings, published in the April 2005 issue of Nature Medicine, suggest that medicines designed to block CaM kinase activity may be useful for treating patients with structural heart disease and myocardial dysfunction.
Heart disease remains the No. 1 killer in the United States. Most of that disease...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Heart Disease Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.